BioSpace News Archive

Job Trends

Caris Life Sciences Data Highlighted During ASCO Presentation Showing Cascading Effects of Tumor Repair Gene Mutations and Tumor Cell Phenotype

Caris Life Sciences® announced the oral presentation of a study demonstrating the value of the large-scale cancer genomic database underlying the company’s proprietary Caris Molecular Intelligence® tumor profiling service

June 4, 2018
·
5 min read
Business

Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy

Codiak BioSciences, Inc announced the appointment of Richard Brudnick as Chief Business Officer and Head of Strategy.

June 4, 2018
·
3 min read
BioMidwest

Viscus Biologics Introduces New Solubilized Collagen Bioink for Use in Bioprinting, Drug Screening and Regenerative Medicine

Viscus Biologics, LLC announces the launch of its new high concentration solubilized collagen for use in drug screening and testing, available for consideration at BIO International.

June 4, 2018
·
2 min read
Drug Development

Vaxart Reports Topline Results from Phase 2 Trial of Teslexivir™ for the Treatment of Condyloma

Vaxart, Inc. reported the topline results from a Phase 2 clinical trial evaluating the safety and efficacy of an antiviral teslexivir 5% gel.

June 4, 2018
·
6 min read
BioMidwest

Exicure, Inc. to Present at Jefferies 2018 Healthcare Conference on June 8th at 2:30 p.m. EDT

Exicure, Inc. announced that Dr. David Giljohann, Chief Executive Officer of Exicure, will present at the Jefferies 2018 Healthcare Conference.

June 4, 2018
·
1 min read
Drug Development

Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Myelodysplastic Syndromes at the ASCO 2018 Annual Meeting

Acceleron Pharma Inc. announced updated results from the Phase 2 trials of luspatercept in patients with lower-risk myelodysplastic syndromes (MDS) at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting.

June 4, 2018
·
6 min read
ENYO Pharma Raises €40 Million in Series B Fundraising

ENYO Pharma announced that it has completed a €40 million Series B round of financing from US and European investors.

June 4, 2018
·
8 min read
Business

Alimera Sciences Terminates At-the-Market Offering Agreement

Terminated its October 2017 agreement for an investment bank to sell up to $25 million in shares of its common stock in an “at-the-market” equity program.

June 4, 2018
·
4 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Long-Term Survival Benefit Based on Four and Five Years of Follow-Up from Two Pivotal Studies in Advanced Melanoma

New Analysis of Four-Year Data for KEYTRUDA from Phase 3 KEYNOTE-006 Study Showed 86 Percent of Patients Were Progression-Free 20 Months After Completing Two Years of KEYTRUDA

June 4, 2018
·
30 min read
Targovax to Present at Jefferies 2018 Global Healthcare Conference

Targovax ASA announces that CMO Magnus Jäderberg will present a company overview at the Jefferies 2018 Global Healthcare Conference.

June 4, 2018
·
2 min read